scholarly journals Is an Antenatal Screening for Chlamydia trachomatis Necessary in the Current Society?

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Marta Dorado Criado ◽  
Celia Fabra Garrido ◽  
Elena Merino San Martín ◽  
Carolina González Arboleya ◽  
Bartolomé Gómez-Arroyo ◽  
...  
Keyword(s):  
Chlamydia Trachomatis ◽  
Antenatal Screening

scholarly journals Lost opportunity to save newborn lives: variable national antenatal screening policies for Neisseria gonorrhoeae and Chlamydia trachomatis

2016 ◽  
Vol 28 (7) ◽  
pp. 660-666 ◽  
Author(s):  
Alexandra Medline ◽  
Dvora Joseph Davey ◽  
Jeffrey D Klausner
Keyword(s):  
United States ◽  
New Zealand ◽  
Chlamydia Trachomatis ◽  
Neisseria Gonorrhoeae ◽  
Pregnant Women ◽  
National Level ◽  
The United States ◽  
World Health ◽  
Antenatal Screening ◽  
Ministry Of Health

Unfavorable pregnancy outcomes caused by Chlamydia trachomatis or Neisseria gonorrhoeae infection are well known. The first step in addressing antenatal C. trachomatis and N. gonorrhoeae infection is a national policy to screen all pregnant women for C. trachomatis and N. gonorrhoeae, regardless of symptoms. The aim of this study was to inform policy makers on the presence of antenatal screening recommendations for C. trachomatis and N. gonorrhoeae infection. We conducted a three-part study from June 2015 to February 2016. We analyzed English and French language information online on Ministry of Health websites regarding C. trachomatis and N. gonorrhoeae antenatal screening. We referenced both primary official country and regional policy documents. We contacted the Ministry of Health directly if the information on the national antenatal screening was outdated or unavailable. In parallel, we sent a survey to the regional representative from the World Health Organization to help collect country-level data. Fourteen countries have current policies for antenatal screening of C. trachomatis and/or N. gonorrhoeae infection: Australia, the Bahamas, Bulgaria, Canada, Estonia, Japan, Germany, Latvia, New Zealand, Democratic People’s Republic of Korea, Romania, Sweden, the United Kingdom, and the United States. Australia, New Zealand, and Latvia and the United States restricted antenatal screening to women ≤25 years old and those of higher risk. Several countries responded that they had policies to treat pregnant women with symptoms. This is the currently recommended WHO guideline but is not the same as universal screening. North Korea had policies in place which were not implemented due to lack of personnel and/or supplies. National level policies to support routine screening for C. trachomatis and N. gonorrhoeae infection to prevent adverse pregnancy and newborn outcomes are uncommon.

scholarly journals Chlamydia trachomatis screening in pregnancy in New Zealand: translation of national guidelines into practice

2015 ◽  
Vol 7 (1) ◽  
pp. 65 ◽  
Author(s):  
Michelle Wise ◽  
Lynn Sadler ◽  
Alec Ekeroma
Keyword(s):  
New Zealand ◽  
Chlamydia Trachomatis ◽  
Pregnant Women ◽  
Antenatal Screening ◽  
National Guidelines ◽  
Ministry Of Health ◽  
Transmitted Infection ◽  
Management Guidelines ◽  
Sexually Transmitted ◽  
In Pregnancy

INTRODUCTION: Chlamydia trachomatis (C. trachomatis) is a common sexually transmitted infection (STI), and routine antenatal screening to reduce the risk of vertical transmission is recommended in New Zealand (NZ). AIM: To determine the proportion of pregnant women who have been screened for C. trachomatis in selected hospitals since the 2008 NZ Ministry of Health Chlamydia Management Guidelines were published, and to examine variation by age and ethnicity. METHODS: Clinical audits were undertaken at four NZ hospitals, using electronic databases to determine if C. trachomatis screening had occurred. RESULTS: Only 24%, 31%, 35% and 61% of pregnant women were screened in Tauranga (2010), Auckland (2013), Waikato (2013) and Middlemore (2011) hospitals, respectively. DISCUSSION: Despite increases in the proportion of pregnant women screened in Auckland and Middlemore compared to pre-2008, and higher proportions of young women and Maori women screened, overall antenatal screening for C. trachomatis remains suboptimal. Several strategies are presented to support universal screening in pregnancy, as recommended by the NZ Ministry of Health. KEYWORDS: Chlamydia trachomatis; mass screening; medical audit; pregnancy

Screening auf Chlamydia trachomatis Infektion in der Schwangerschaft

2008 ◽  
Vol 68 (S 01) ◽  
Author(s):  
TM Weissenbacher ◽  
A Gingelmaier ◽  
M Kupka ◽  
F Kainer ◽  
K Friese ◽  
...  
Keyword(s):  
Chlamydia Trachomatis

Udział atypowego patogenu Chlamydia trachomatis w zapaleniach cewki moczowej

2016 ◽  
Vol 7 (6) ◽  
pp. 425-428
Author(s):  
Magdalena Frej-Mądrzak ◽  
Jolanta Sarowska ◽  
Agnieszka Jama-Kmiecik ◽  
Dorota Teryks-Wołyniec ◽  
Irena Choroszy-Król
Keyword(s):  
Chlamydia Trachomatis

MYCOPLASMA AND CHLAMYDIA AS ETHIOLOGICAL FACTORS OF BRONCHIAL ASTHMA IN TERMS OF ETHNOGENESIS

2013 ◽  
Vol 68 (7) ◽  
pp. 57-60
Author(s):  
O. A. Sharavii ◽  
S. V. Smirnova
Keyword(s):  
Immune Response ◽  
Chlamydia Trachomatis ◽  
Blood Serum ◽  
Bronchial Asthma ◽  
Mycoplasma Hominis ◽  
Acute Stage ◽  
Control Group ◽  
Clinical Markers ◽  
Chlamydophila Psittaci ◽  
Asthma Patients

 Aim. The study of the prevalence and clinical peculiarities of Mycoplasmosis and Chlamydiosis in patients with different pathogenic forms of bronchial asthma (BA) taking into account ethnicity of a patient. Subjects and Methods. The research covered 239 subjects – both the Europeoids and the Mongoloids in the city of Krasnoyarsk and the town of Kyzyl, all of them being BA patients of different stages, including acute stage and practically healthy. We had determined antigens Mycoplasma pneumoniae, Mycoplasma hominis, Chlamydophila pneumoniae, Chlamydophila psittaci and Chlamydia trachomatis in smears of mucosa of pharynx and antibodies to these antigens in peripheral blood serum. Results.  We found high frequency of Mycoplasmosis and Chlamydiosis in the inhabitants of Eastern Siberia, BA patients with different pathogenic forms as compared to control group. We had determined ethnic peculiarities of specific immune response: IgM to М. pneumoniae was revealed in the Europoids more frequently than in the Mongoloids, but IgM to С. pneumoniae and to C. trachomatis, C. trachomatis antigens had been revealed more often in the Mongoloids than in the Europoids. We accepted as clinical equivalents of Mycoplasmosis and Chlamydiosis diagnostics the following signs: temperature around 37C (subfebrile temperature), non-intensive but stable coughing with scanty mucous and muco-purulent sputum, dyspnea of mixed character. Conclusions. Mycoplasma and Chlamydia are meaningful etiologic factors of bronchial asthma. We have found the peculiarities of immune response depending on ethnicity of a patient (ethnic belonging). Clinical markers of Mycoplasmosis and Chlamydiosis should be taken into account in bronchial asthma in order to provide diagnostics timely as well as eradication of infection agents. Because of insufficient knowledge of problem of bronchial asthma related to contamination with Мycoplasma and Chlamydia we put the goal to study the frequency of Mycoplasmosis and Chlamydiosis occurrence in bronchial asthma patients and determine the characteristics clinical course of diseases. We defined antigens Мycoplasma pneumoniae, Мycoplasma hominis, Chlamydophila pneumoniaе, Chlamydophila psittaci, Chlamydia trachomatis in smears of oropharynx mucosa and antibodies to them in blood serum. 

Sign in / Sign up

Export Citation Format

Share Document